Clinical Trial Update: Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating zanamivir for treatment of dengue-related vascular permeability; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever

Drugs mentioned

• Zanamivir (zanamivir)

Snippet

Sponsor: George Washington University | Conditions: Dengue Fever | Phase 2 | Status: RECRUITING